Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary pOsterioR TRacheopexy Prevents Collapse of the Trachea in Newborns With Oesophageal AtresIa and Tracheomalacia

NCT06335862 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT06335862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06335862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary pOsterioR TRacheopexy Prevents Collapse of the Trachea in Newborns With Oesophageal AtresIa and Tracheomalacia
Lead sponsor
UMC Utrecht
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
September 1, 2024
Completion date
September 1, 2027
Enrollment
78 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

oesophageal atresia, oesophageal atresia with tracheo-oesophageal fistula, tracheomalacia